Women with advanced or recurring ovarian, peritoneal, or fallopian tube cancer may be eligible to participate in a new clinical trial offered by Sarasota Memorial’s Kolschowsky Research and Education Institute.
Thursday, October 2, 2025
Clinical trial testing the efficacy of an experimental immunotherapeutic drug, Olvi-Vec.
Thursday, October 2, 2025
Sarasota Memorial's Kolschowsky Research and Education Institute is among 10 research sites studying an investigational device designed to reduce the risk of bleeding complications in patients undergoing hemodialysis treatment.
Thursday, October 2, 2025